MDXG Competitors & Alternatives
Compare MiMedx Group Inc with similar stocks in the same industry
Biotechnology
MDXG
Main Stock$3.91
Tradestie Score
47
Market Cap
$1.01B
P/E Ratio
93.5
Revenue Growth
-0.3%
Analyst Upside
+89.3%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SVRA
Savara Inc.
|
$4.22
|
$611.84M | - | 55 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$2.32
|
$552.46M | - | 66 | Compare |
|
VSTM
Verastem, Inc.
|
$10.04
|
$541.60M | - | 44 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.53
|
$540.97M | - | 57 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.81
|
$529.35M | 11.4 | 56 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.42
|
$512.39M | - | 46 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$48.13
|
$505.12M | 2.8 | 59 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$93.38
|
$492.21M | - | 53 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
More MDXG Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 3841)
221 stocks in this industry